ABL Bio Inc. (298380) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ABL Bio Inc. (298380:KRX), powered by AI.
- Current Price
- ₩126,400
- P/E Ratio
- -187.2
- Market Cap
- 7.1T
- Sector
- Healthcare
What is the ABL Bio Inc. stock price forecast?
ABL Bio Inc. is currently trading at ₩126,400. View real-time AI analysis on Alpha Lenz.
What is ABL Bio Inc. insider trading activity?
View the latest insider trading data for ABL Bio Inc. on Alpha Lenz.
What is ABL Bio Inc.'s P/E ratio?
ABL Bio Inc.'s P/E ratio is -187.2.
ABL Bio Inc.
KRX · 298380“ABL Bio Inc. trades at a P/E of -187.2 (undervalued) with modest ROE of -23.5%.”
Ask for details →Company Overview
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“ABL Bio Inc. trades at a P/E of -187.2 (undervalued) with modest ROE of -23.5%.”
Ask for details →Frequently Asked Questions
ABL Bio Inc. (ticker: 298380) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 102 employees. Market cap is $7.1T.
The current price is ₩126,400 with a P/E ratio of -187.19x and P/B of 45.74x.
ROE is -23.48% and operating margin is -50.76%. Annual revenue is $79.3B.